Cargando…
The COVID-19 pandemic: a catalyst to improve clinical trials
The COVID-19 pandemic has provided the vital stepping stones to improve how clinical trials are conducted. We provide an overview of the major changes to the clinical trial process instigated by the pandemic and suggest ways to make these changes sustainable.
Autores principales: | Gaba, Prakriti, Bhatt, Deepak L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461742/ https://www.ncbi.nlm.nih.gov/pubmed/32873977 http://dx.doi.org/10.1038/s41569-020-00439-7 |
Ejemplares similares
-
Recruitment Practices in Multicenter Randomized Clinical Trials: Time for a Relook
por: Gaba, Prakriti, et al.
Publicado: (2021) -
Over, Under, or Just Right? How do we interpret ICD utilization in the modern era?
por: Gaba, Prakriti, et al.
Publicado: (2016) -
Challenges in operationalising clinical trials in India during the COVID-19 pandemic
por: Bassi, Abhinav, et al.
Publicado: (2022) -
Early-phase clinical trials in a pandemic: learning from the response to COVID-19
por: Horsley, Alex, et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic on clinical research
por: Tuttle, Katherine R.
Publicado: (2020)